Osteoporosis[Mesh] AND Hormone Replacement Therapy[Mesh] - Search Results

Year	Number of Results
1989	3
1990	7
1991	9
1992	7
1993	14
1994	4
1995	8
1996	11
1997	20
1998	14
1999	20
2000	25
2001	19
2002	28
2003	35
2004	34
2005	16
2006	17
2007	20
2008	20
2009	13
2010	16
2011	19
2012	13
2013	5
2014	10
2015	11
2016	9
2017	8
2018	8
2019	7
2020	11
2021	5
2022	4
2023	3
2024	4

1

Bone mineral density: Comparison between women under hormone replacement therapy with Turner syndrome or idiopathic premature ovarian insufficiency.

Nelis C, Belin L, Tejedor I, Dulon J, Bachelot A, Chakhtoura Z. Nelis C, et al. Ann Endocrinol (Paris). 2024 Dec;85(6):574-581. doi: 10.1016/j.ando.2024.07.004. Epub 2024 Aug 5. Ann Endocrinol (Paris). 2024. PMID: 39111694 Free article.

2

Role of bisphosphonates in osteoporosis caused by adult growth hormone deficiency.

Cheng Z, Li J, Chen Z, Ren W. Cheng Z, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Jun 28;49(6):839-847. doi: 10.11817/j.issn.1672-7347.2024.230469. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39311779 Free PMC article. Review.

3

Factors associated with low bone mineral density in Turner syndrome: a multicenter prospective observational study.

Ikegawa K, Koga E, Itonaga T, Sakakibara H, Kawai M, Hasegawa Y. Ikegawa K, et al. Endocr J. 2024 Jun 18;71(6):561-569. doi: 10.1507/endocrj.EJ23-0628. Epub 2024 Mar 22. Endocr J. 2024. PMID: 38522940 Free article.

4

Antiosteoporosis therapy after discontinuation of menopausal hormone therapy: a systematic review.

Anagnostis P, Divaris E, Bosdou JΚ, Tournis S, Stathopoulos K, Goulis DG. Anagnostis P, et al. Hormones (Athens). 2024 Jun;23(2):339-344. doi: 10.1007/s42000-024-00526-1. Epub 2024 Jan 18. Hormones (Athens). 2024. PMID: 38236381 Free PMC article. Review.

5

Discontinuation of hormone therapy and bone mineral density: does physical activity modify that relationship?

Sheedy AN, Wactawski-Wende J, Hovey KM, LaMonte MJ. Sheedy AN, et al. Menopause. 2023 Dec 1;30(12):1199-1205. doi: 10.1097/GME.0000000000002272. Epub 2023 Oct 31. Menopause. 2023. PMID: 38019034 Free PMC article.

6

Subcutaneous testosterone pellet therapy for reversal of male osteoporosis: a review and case report.

Dorr B, Abdelaziz A, Karram M. Dorr B, et al. Aging Male. 2023 Dec;26(1):2181953. doi: 10.1080/13685538.2023.2181953. Aging Male. 2023. PMID: 36912031 Free article. Review.

7

Osteoporosis in men with hypogonadism because of ApoA-I Leu75Pro amyloidosis under long-term testosterone therapy.

Facondo P, Delbarba A, Pezzaioli LC, Ferlin A, Cappelli C. Facondo P, et al. Andrology. 2023 Sep;11(6):1077-1085. doi: 10.1111/andr.13376. Epub 2023 Jan 23. Andrology. 2023. PMID: 36624081 Free article.

8

Exploring the regulatory mechanism of osteoporosis based on intestinal flora: A review.

Awuti K, Wang X, Sha L, Leng X. Awuti K, et al. Medicine (Baltimore). 2022 Dec 30;101(52):e32499. doi: 10.1097/MD.0000000000032499. Medicine (Baltimore). 2022. PMID: 36596003 Free PMC article. Review.

9

Facing Osteoporosis: Is Hormonal Therapy Losing an Opportunity to be Used? The Role of Gynecologists.

Sá MFS. Sá MFS. Rev Bras Ginecol Obstet. 2022 Nov;44(11):1011-1013. doi: 10.1055/s-0042-1760116. Epub 2022 Dec 29. Rev Bras Ginecol Obstet. 2022. PMID: 36580945 Free PMC article. No abstract available.

10

Update on hormone therapy for the management of postmenopausal women.

Pan M, Pan X, Zhou J, Wang J, Qi Q, Wang L. Pan M, et al. Biosci Trends. 2022 Mar 11;16(1):46-57. doi: 10.5582/bst.2021.01418. Epub 2022 Jan 10. Biosci Trends. 2022. PMID: 35013031 Free article. Review.

11

Characteristics of Long-Term Femoral Neck Bone Loss in Postmenopausal Women: A 25-Year Follow-Up.

Moilanen A, Kopra J, Kröger H, Sund R, Rikkonen T, Sirola J. Moilanen A, et al. J Bone Miner Res. 2022 Feb;37(2):173-178. doi: 10.1002/jbmr.4444. Epub 2021 Oct 19. J Bone Miner Res. 2022. PMID: 34668233 Free PMC article.

12

Management of Osteoporosis in Men: A Narrative Review.

Vescini F, Chiodini I, Falchetti A, Palermo A, Salcuni AS, Bonadonna S, De Geronimo V, Cesareo R, Giovanelli L, Brigo M, Bertoldo F, Scillitani A, Gennari L. Vescini F, et al. Int J Mol Sci. 2021 Dec 20;22(24):13640. doi: 10.3390/ijms222413640. Int J Mol Sci. 2021. PMID: 34948434 Free PMC article. Review.

13

Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women.

Reeves KW, Vieyra G, Grimes NP, Meliker J, Jackson RD, Wactawski-Wende J, Wallace R, Zoeller RT, Bigelow C, Hankinson SE, Manson JE, Cauley JA, Calafat AM. Reeves KW, et al. J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2567-e2579. doi: 10.1210/clinem/dgab189. J Clin Endocrinol Metab. 2021. PMID: 33754148 Free PMC article.

14

Dilemmas in management of osteoporosis in patients with complete androgen insensitivity syndrome.

Slayden T, Bauer EM, Shakir MK, Hoang TD. Slayden T, et al. BMJ Case Rep. 2021 May 12;14(5):e241968. doi: 10.1136/bcr-2021-241968. BMJ Case Rep. 2021. PMID: 33980561 Free PMC article.

15

Late-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations.

Jaschke N, Wang A, Hofbauer LC, Rauner M, Rachner TD. Jaschke N, et al. Ageing Res Rev. 2021 May;67:101301. doi: 10.1016/j.arr.2021.101301. Epub 2021 Feb 18. Ageing Res Rev. 2021. PMID: 33610812 Free PMC article. Review.

16

Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?

Rozenberg S, Al-Daghri N, Aubertin-Leheudre M, Brandi ML, Cano A, Collins P, Cooper C, Genazzani AR, Hillard T, Kanis JA, Kaufman JM, Lambrinoudaki I, Laslop A, McCloskey E, Palacios S, Prieto-Alhambra D, Reginster JY, Rizzoli R, Rosano G, Trémollieres F, Harvey NC. Rozenberg S, et al. Osteoporos Int. 2020 Dec;31(12):2271-2286. doi: 10.1007/s00198-020-05497-8. Epub 2020 Jul 8. Osteoporos Int. 2020. PMID: 32642851 Free PMC article. Review.

17

Late-onset Hypogonadism: Bone health.

Rochira V. Rochira V. Andrology. 2020 Nov;8(6):1539-1550. doi: 10.1111/andr.12827. Epub 2020 Jun 17. Andrology. 2020. PMID: 32469467 Free article. Review.

18

A retrospective multicenter study of bone mineral density in adolescents and adults with Turner syndrome in Japan.

Itonaga T, Koga E, Nishigaki S, Kawai M, Sakakibara H, Hasegawa Y. Itonaga T, et al. Endocr J. 2020 Oct 28;67(10):1023-1028. doi: 10.1507/endocrj.EJ20-0083. Epub 2020 Jun 18. Endocr J. 2020. PMID: 32554947 Free article.

19

Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs.

Fuggle NR, Cooper C, Harvey NC, Al-Daghri N, Brandi ML, Bruyere O, Cano A, Dennison EM, Diez-Perez A, Kaufman JM, Palacios S, Prieto-Alhambra D, Rozenberg S, Thomas T, Tremollieres F, Rizzoli R, Kanis JA, Reginster JY. Fuggle NR, et al. Drugs. 2020 Oct;80(15):1537-1552. doi: 10.1007/s40265-020-01364-2. Drugs. 2020. PMID: 32725307 Free PMC article. Review.

20

Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.

Pepe J, Body JJ, Hadji P, McCloskey E, Meier C, Obermayer-Pietsch B, Palermo A, Tsourdi E, Zillikens MC, Langdahl B, Ferrari S. Pepe J, et al. J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa306. doi: 10.1210/clinem/dgaa306. J Clin Endocrinol Metab. 2020. PMID: 32453819 Free article. Review.

21

Is there still a role for SERMs in menopause management?

Lello S, Capozzi A, Scambia G. Lello S, et al. Gynecol Endocrinol. 2020 Jul;36(7):567-568. doi: 10.1080/09513590.2020.1779691. Epub 2020 Jun 12. Gynecol Endocrinol. 2020. PMID: 32530328 Free article. No abstract available.

22

Osteoporosis Management in the Era of COVID-19.

Yu EW, Tsourdi E, Clarke BL, Bauer DC, Drake MT. Yu EW, et al. J Bone Miner Res. 2020 Jun;35(6):1009-1013. doi: 10.1002/jbmr.4049. Epub 2020 May 26. J Bone Miner Res. 2020. PMID: 32406536 Free PMC article.

23

Decreased bone mineral density and reproductive axis dysfunction: more than oestrogen.

DeLoughery EP, Dow ML. DeLoughery EP, et al. Neth J Med. 2020 Mar;78(2):50-54. Neth J Med. 2020. PMID: 32332177 Free article. Review.

24

EDTA-Modified 17β-Estradiol-Laden Upconversion Nanocomposite for Bone-Targeted Hormone Replacement Therapy for Osteoporosis.

Chen X, Zhu X, Hu Y, Yuan W, Qiu X, Jiang T, Xia C, Xiong L, Li F, Gao Y. Chen X, et al. Theranostics. 2020 Feb 10;10(7):3281-3292. doi: 10.7150/thno.37599. eCollection 2020. Theranostics. 2020. PMID: 32194868 Free PMC article.

25

Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence.

Mohamad NV, Ima-Nirwana S, Chin KY. Mohamad NV, et al. Endocr Metab Immune Disord Drug Targets. 2020;20(9):1478-1487. doi: 10.2174/1871530320666200604160614. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 32496996 Free PMC article. Review.

26

Skeletal Effects of Levothyroxine for Subclinical Hypothyroidism in Older Adults: A TRUST Randomized Trial Nested Study.

Gonzalez Rodriguez E, Stuber M, Del Giovane C, Feller M, Collet TH, Löwe AL, Blum MR, van Vliet NA, van Heemst D, Kearney PM, Gussekloo J, Mooijaart S, Westendorp RGJ, Stott DJ, Aeberli D, Bauer DC, Hans D, Rodondi N. Gonzalez Rodriguez E, et al. J Clin Endocrinol Metab. 2020 Jan 1;105(1):dgz058. doi: 10.1210/clinem/dgz058. J Clin Endocrinol Metab. 2020. PMID: 31702015 Free article. Clinical Trial.

27

Update on Menopausal Hormone Therapy for Fracture Prevention.

Stepan JJ, Hruskova H, Kverka M. Stepan JJ, et al. Curr Osteoporos Rep. 2019 Dec;17(6):465-473. doi: 10.1007/s11914-019-00549-3. Curr Osteoporos Rep. 2019. PMID: 31741221 Free PMC article. Review.

28

Turner syndrome and Cushing disease - the coexistence with overlapping complications: case report and literature review.

Gniewek K, Brona A, Jędrzejuk D, Kolačkov K, Bolanowski M. Gniewek K, et al. Gynecol Endocrinol. 2019 Dec;35(12):1015-1020. doi: 10.1080/09513590.2019.1631281. Epub 2019 Jun 27. Gynecol Endocrinol. 2019. PMID: 31242778 Free article. Review.

29

A Nutraceutical Approach to Menopausal Complaints.

De Franciscis P, Colacurci N, Riemma G, Conte A, Pittana E, Guida M, Schiattarella A. De Franciscis P, et al. Medicina (Kaunas). 2019 Aug 28;55(9):544. doi: 10.3390/medicina55090544. Medicina (Kaunas). 2019. PMID: 31466381 Free PMC article. Review.

30

Angiogenesis Changes in Ovariectomized Rats with Osteoporosis Treated with Estrogen Replacement Therapy.

Zhang Y, Hua F, Ding K, Chen H, Xu C, Ding W. Zhang Y, et al. Biomed Res Int. 2019 Jul 4;2019:1283717. doi: 10.1155/2019/1283717. eCollection 2019. Biomed Res Int. 2019. PMID: 31355247 Free PMC article.

31

Women's health 2019: Osteoporosis, breast cancer, contraception, and hormone therapy.

Moreno AC, Sahni SK, Smith TL, Batur P. Moreno AC, et al. Cleve Clin J Med. 2019 Jun;86(6):400-406. doi: 10.3949/ccjm.86a.18130. Cleve Clin J Med. 2019. PMID: 31204979 Free article. Review.

32

Osteoporosis and Bone Health in Transgender Persons.

Stevenson MO, Tangpricha V. Stevenson MO, et al. Endocrinol Metab Clin North Am. 2019 Jun;48(2):421-427. doi: 10.1016/j.ecl.2019.02.006. Epub 2019 Mar 23. Endocrinol Metab Clin North Am. 2019. PMID: 31027549 Free PMC article. Review.

33

Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.

Antonio L, Caerels S, Jardi F, Delaunay E, Vanderschueren D. Antonio L, et al. Andrology. 2019 May;7(3):302-306. doi: 10.1111/andr.12604. Epub 2019 Mar 8. Andrology. 2019. PMID: 30851011 Free article.

34

[Does menopause hormone therapy reduce the risk of chronic diseases?].

Blümel JE, Arteaga E. Blümel JE, et al. Rev Med Chil. 2018 Dec;146(10):1170-1174. doi: 10.4067/S0034-98872018001001170. Rev Med Chil. 2018. PMID: 30724981 Free article. Spanish.

35

Factors associated with the initiation of testosterone replacement therapy in men from the 45 and Up Study.

Cheng Y, Bateson D, Concepcion K, Stewart M, Lowy M, Sweeney S, Estoesta J, McGeechan K. Cheng Y, et al. Aust J Gen Pract. 2018 Oct;47(10):698-704. doi: 10.31128/AJGP-02-18-4480. Aust J Gen Pract. 2018. PMID: 31195775 Free article.

36

What do TSECs provide in the menopausal hormone therapy?

Llaneza P, Calaf J, Jurado AR, Mendoza N, Otero B, Quereda F, Sánchez-Borrego R, Lubian D. Llaneza P, et al. Gynecol Endocrinol. 2018 Oct;34(10):826-832. doi: 10.1080/09513590.2018.1474869. Epub 2018 May 23. Gynecol Endocrinol. 2018. PMID: 29790381 Free article. Review.

37

The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women.

Mondockova V, Adamkovicova M, Lukacova M, Grosskopf B, Babosova R, Galbavy D, Martiniakova M, Omelka R. Mondockova V, et al. BMC Med Genet. 2018 Sep 21;19(1):174. doi: 10.1186/s12881-018-0684-8. BMC Med Genet. 2018. PMID: 30241506 Free PMC article.

38

Tissue selective estrogen complex (TSEC): a review.

Pickar JH, Boucher M, Morgenstern D. Pickar JH, et al. Menopause. 2018 Sep;25(9):1033-1045. doi: 10.1097/GME.0000000000001095. Menopause. 2018. PMID: 29533367 Free PMC article. Review.

39

Patterns of menopausal hormone therapy use and hyperkyphosis in older women.

Woods GN, Huang MH, Cawthon PM, McDaniels-Davidson C, Fink HA, Kado DM; Study of Osteoporotic Fractures (SOF) Research Group. Woods GN, et al. Menopause. 2018 Jul;25(7):738-743. doi: 10.1097/GME.0000000000001070. Menopause. 2018. PMID: 29462096 Free PMC article.

40

Eldecalcitol increases bone mass in patients with Turner syndrome who have insufficient bone mass acquisition after estrogen replacement therapy.

Tsuburai T, Nakamura T, Yoshikata H, Miyagi E, Sakakibara H. Tsuburai T, et al. Endocr J. 2018 Jun 27;65(6):629-638. doi: 10.1507/endocrj.EJ17-0498. Epub 2018 Mar 31. Endocr J. 2018. PMID: 29607913 Free article.

41

[Estrogens in menopause – time to change the guidelines?].

Eriksen EF, Moen MH, Iversen OE. Eriksen EF, et al. Tidsskr Nor Laegeforen. 2018 Mar 19;138(6). doi: 10.4045/tidsskr.17.1059. Print 2018 Mar 20. Tidsskr Nor Laegeforen. 2018. PMID: 29557135 Free article. Norwegian. No abstract available.

42

The biological and clinical advances of androgen receptor function in age-related diseases and cancer [Review].

Takayama KI. Takayama KI. Endocr J. 2017 Oct 28;64(10):933-946. doi: 10.1507/endocrj.EJ17-0328. Epub 2017 Aug 19. Endocr J. 2017. PMID: 28824023 Free article. Review.

43

A theory of eu-estrogenemia: a unifying concept.

Turner RJ, Kerber IJ. Turner RJ, et al. Menopause. 2017 Sep;24(9):1086-1097. doi: 10.1097/GME.0000000000000895. Menopause. 2017. PMID: 28562489 Free PMC article. Review.

44

Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study).

Shigehara K, Konaka H, Koh E, Nakashima K, Iijima M, Nohara T, Izumi K, Kitagawa Y, Kadono Y, Sugimoto K, Iwamoto T, Mizokami A, Namiki M. Shigehara K, et al. Aging Male. 2017 Sep;20(3):139-145. doi: 10.1080/13685538.2017.1303829. Epub 2017 Mar 28. Aging Male. 2017. PMID: 28347184 Free article. Clinical Trial.

45

Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.

Laine CM, Landin-Wilhelmsen K. Laine CM, et al. Osteoporos Int. 2017 Jul;28(7):2247-2250. doi: 10.1007/s00198-017-3981-8. Epub 2017 Mar 21. Osteoporos Int. 2017. PMID: 28324131 Free PMC article.

46

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians.

Qaseem A, Forciea MA, McLean RM, Denberg TD; Clinical Guidelines Committee of the American College of Physicians; Barry MJ, Cooke M, Fitterman N, Harris RP, Humphrey LL, Kansagara D, McLean RM, Mir TP, Schünemann HJ. Qaseem A, et al. Ann Intern Med. 2017 Jun 6;166(11):818-839. doi: 10.7326/M15-1361. Epub 2017 May 9. Ann Intern Med. 2017. PMID: 28492856 Free article.

47

Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.

Owen PJ, Daly RM, Livingston PM, Fraser SF. Owen PJ, et al. Prostate Cancer Prostatic Dis. 2017 Jun;20(2):137-145. doi: 10.1038/pcan.2016.69. Epub 2017 Jan 24. Prostate Cancer Prostatic Dis. 2017. PMID: 28117386 Free PMC article. Review.

48

Will women be swayed by HRT's preventive benefits?

Vogel L. Vogel L. CMAJ. 2017 May 8;189(18):E676-E677. doi: 10.1503/cmaj.1095423. CMAJ. 2017. PMID: 28483853 Free PMC article. No abstract available.

49

No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative.

Watts NB, Cauley JA, Jackson RD, LaCroix AZ, Lewis CE, Manson JE, Neuner JM, Phillips LS, Stefanick ML, Wactawski-Wende J, Crandall C; Women’s Health Initiative Investigators. Watts NB, et al. J Clin Endocrinol Metab. 2017 Jan 1;102(1):302-308. doi: 10.1210/jc.2016-3270. J Clin Endocrinol Metab. 2017. PMID: 27820659 Free PMC article. Clinical Trial.

50

Poor Compliance to Hormone Therapy and Decreased Bone Mineral Density in Women with Premature Ovarian Insufficiency.

Bachelot A, Nicolas C, Gricourt S, Dulon J, Leban M, Golmard JL, Touraine P. Bachelot A, et al. PLoS One. 2016 Dec 1;11(12):e0164638. doi: 10.1371/journal.pone.0164638. eCollection 2016. PLoS One. 2016. PMID: 27906970 Free PMC article.

51

The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal.

Papadakis G, Hans D, Gonzalez-Rodriguez E, Vollenweider P, Waeber G, Marques-Vidal PM, Lamy O. Papadakis G, et al. J Clin Endocrinol Metab. 2016 Dec;101(12):5004-5011. doi: 10.1210/jc.2016-2695. Epub 2016 Nov 17. J Clin Endocrinol Metab. 2016. PMID: 27854548 Free article.

52

Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause.

Lobo RA, Pickar JH, Stevenson JC, Mack WJ, Hodis HN. Lobo RA, et al. Atherosclerosis. 2016 Nov;254:282-290. doi: 10.1016/j.atherosclerosis.2016.10.005. Epub 2016 Oct 6. Atherosclerosis. 2016. PMID: 27745704 Free article. Review.

53

Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.

van Varsseveld NC, van Bunderen CC, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML. van Varsseveld NC, et al. Pituitary. 2016 Aug;19(4):381-90. doi: 10.1007/s11102-016-0716-3. Pituitary. 2016. PMID: 27048484 Free PMC article.

54

Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.

LaFleur J, Rillamas-Sun E, Colón-Emeric CS, Knippenberg KA, Ensrud KE, Gray SL, Cauley JA, LaCroix AZ. LaFleur J, et al. Gerontologist. 2016 Feb;56 Suppl 1(Suppl 1):S78-90. doi: 10.1093/geront/gnv677. Gerontologist. 2016. PMID: 26768394 Free PMC article.

55

Luteinizing hormone downregulation but not estrogen replacement improves ovariectomy-associated cognition and spine density loss independently of treatment onset timing.

Blair JA, Palm R, Chang J, McGee H, Zhu X, Wang X, Casadesus G. Blair JA, et al. Horm Behav. 2016 Feb;78:60-6. doi: 10.1016/j.yhbeh.2015.10.013. Epub 2015 Oct 21. Horm Behav. 2016. PMID: 26497249 Free PMC article.

56

Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.

Sinha P, Aarnisalo P, Chubb R, Poulton IJ, Guo J, Nachtrab G, Kimura T, Swami S, Saeed H, Chen M, Weinstein LS, Schipani E, Sims NA, Kronenberg HM, Wu JY. Sinha P, et al. J Biol Chem. 2016 Jan 22;291(4):1631-1642. doi: 10.1074/jbc.M115.679753. Epub 2015 Nov 23. J Biol Chem. 2016. PMID: 26598522 Free PMC article.

57

New aspects of postmenopausal osteoporosis treatment with micronized estradiol and progesterone.

von Mach-Szczypiński J, Stanosz S, Kościuszkiewicz J, Safranow K. von Mach-Szczypiński J, et al. Ginekol Pol. 2016;87(11):739-744. doi: 10.5603/GP.2016.0080. Ginekol Pol. 2016. PMID: 27958631 Free article.

58

Diagnosis and Management of Cirrhosis-Related Osteoporosis.

Santos LA, Romeiro FG. Santos LA, et al. Biomed Res Int. 2016;2016:1423462. doi: 10.1155/2016/1423462. Epub 2016 Oct 20. Biomed Res Int. 2016. PMID: 27840821 Free PMC article. Review.

59

Bone health status of postmenopausal Chinese women.

Lo SS. Lo SS. Hong Kong Med J. 2015 Dec;21(6):536-41. doi: 10.12809/hkmj154527. Epub 2015 Oct 16. Hong Kong Med J. 2015. PMID: 26492837 Free article.

60

Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand.

Wang A, Obertová Z, Brown C, Karunasinghe N, Bishop K, Ferguson L, Lawrenson R. Wang A, et al. BMC Cancer. 2015 Nov 2;15:837. doi: 10.1186/s12885-015-1843-3. BMC Cancer. 2015. PMID: 26525985 Free PMC article.

61

Female aging.

Sorpreso IC, Soares Júnior JM, Fonseca AM, Baracat EC. Sorpreso IC, et al. Rev Assoc Med Bras (1992). 2015 Nov-Dec;61(6):553-6. doi: 10.1590/1806-9282.61.06.553. Rev Assoc Med Bras (1992). 2015. PMID: 26841166 Free article. Review.

62

The smallest available estradiol transdermal patch: a new treatment option for the prevention of postmenopausal osteoporosis.

Bertonazzi A, Nelson B, Salvador J, Umland E. Bertonazzi A, et al. Womens Health (Lond). 2015 Nov;11(6):815-24. doi: 10.2217/whe.15.64. Epub 2015 Nov 30. Womens Health (Lond). 2015. PMID: 26618621 Free article. Review.

63

Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative Study.

Crandall CJ, Hovey KM, Andrews CA, Cauley JA, Manson JE, Wactawski-Wende J, Wright NC, Li W, Beavers K, Curtis JR, LeBoff MS. Crandall CJ, et al. J Clin Endocrinol Metab. 2015 Nov;100(11):4315-24. doi: 10.1210/jc.2015-2568. Epub 2015 Sep 14. J Clin Endocrinol Metab. 2015. PMID: 26367200 Free PMC article.

64

Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women's Health Initiative Observational Study.

Sullivan SD, Lehman A, Thomas F, Johnson KC, Jackson R, Wactawski-Wende J, Ko M, Chen Z, Curb JD, Howard BV. Sullivan SD, et al. Menopause. 2015 Oct;22(10):1035-44. doi: 10.1097/GME.0000000000000451. Menopause. 2015. PMID: 25803670 Free PMC article.

65

Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.

Borst SE, Yarrow JF. Borst SE, et al. Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1035-42. doi: 10.1152/ajpendo.00111.2015. Epub 2015 Apr 21. Am J Physiol Endocrinol Metab. 2015. PMID: 25898953 Free PMC article. Review.

66

Controversies in testosterone supplementation therapy.

Khera M. Khera M. Asian J Androl. 2015 Mar-Apr;17(2):175-6. doi: 10.4103/1008-682X.148728. Asian J Androl. 2015. PMID: 25652639 Free PMC article.

67

Analysis of the Influence of Hormone Replacement Therapy on Osteocalcin Gene Expression in Postmenopausal Women.

Rahnama M, Jastrzębska-Jamrogiewicz I, Jamrogiewicz R, Trybek G. Rahnama M, et al. Biomed Res Int. 2015;2015:416929. doi: 10.1155/2015/416929. Epub 2015 Aug 19. Biomed Res Int. 2015. PMID: 26357654 Free PMC article.

68

Prevention of alveolar bone loss in an osteoporotic animal model via interference of semaphorin 4d.

Zhang Y, Wei L, Miron RJ, Zhang Q, Bian Z. Zhang Y, et al. J Dent Res. 2014 Nov;93(11):1095-100. doi: 10.1177/0022034514552676. Epub 2014 Sep 24. J Dent Res. 2014. PMID: 25252878 Free PMC article.

69

High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio.

Zhang Z, Song C, Fu X, Liu M, Li Y, Pan J, Liu H, Wang S, Xiang L, Xiao GG, Ju D. Zhang Z, et al. Int J Mol Sci. 2014 Sep 25;15(9):17130-47. doi: 10.3390/ijms150917130. Int J Mol Sci. 2014. PMID: 25257532 Free PMC article.

70

The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model.

Arumugam A, Lissner EA, Lakshmanaswamy R. Arumugam A, et al. Reprod Biol Endocrinol. 2014 Jul 15;12:66. doi: 10.1186/1477-7827-12-66. Reprod Biol Endocrinol. 2014. PMID: 25023195 Free PMC article.

71

Prevention and treatment of postmenopausal osteoporosis.

Tella SH, Gallagher JC. Tella SH, et al. J Steroid Biochem Mol Biol. 2014 Jul;142:155-70. doi: 10.1016/j.jsbmb.2013.09.008. Epub 2013 Oct 29. J Steroid Biochem Mol Biol. 2014. PMID: 24176761 Free PMC article. Review.

72

Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.

Smith CL, Santen RJ, Komm B, Mirkin S. Smith CL, et al. Breast Cancer Res. 2014 Jun 18;16(3):212. doi: 10.1186/bcr3677. Breast Cancer Res. 2014. PMID: 25928299 Free PMC article. Review.

73

Management of postmenopausal osteoporosis and the prevention of fractures.

Gambacciani M, Levancini M. Gambacciani M, et al. Panminerva Med. 2014 Jun;56(2):115-31. Epub 2014 Jun 19. Panminerva Med. 2014. PMID: 24942322 Free article.

74

Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass.

Amugongo SK, Yao W, Jia J, Lay YA, Dai W, Jiang L, Walsh D, Li CS, Dave NK, Olivera D, Panganiban B, Ritchie RO, Lane NE. Amugongo SK, et al. Osteoporos Int. 2014 Jun;25(6):1735-50. doi: 10.1007/s00198-014-2678-5. Epub 2014 Apr 11. Osteoporos Int. 2014. PMID: 24722767 Free PMC article.

75

Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study.

Roth JA, Etzioni R, Waters TM, Pettinger M, Rossouw JE, Anderson GL, Chlebowski RT, Manson JE, Hlatky M, Johnson KC, Ramsey SD. Roth JA, et al. Ann Intern Med. 2014 May 6;160(9):594-602. doi: 10.7326/M13-2348. Ann Intern Med. 2014. PMID: 24798522 Free PMC article.

76

[Hormone replacement therapy as primary prevention?].

Eiken P, Vestergaard P, Jensen JE. Eiken P, et al. Ugeskr Laeger. 2014 Mar 17;176(6):V06130367. Ugeskr Laeger. 2014. PMID: 25096207 Free article. Review. Danish.

77

The role of hypogonadism in Klinefelter syndrome.

Høst C, Skakkebæk A, Groth KA, Bojesen A. Høst C, et al. Asian J Androl. 2014 Mar-Apr;16(2):185-91. doi: 10.4103/1008-682X.122201. Asian J Androl. 2014. PMID: 24407186 Free PMC article. Review.

78

Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study.

Bansal N, Katz R, de Boer IH, Kestenbaum B, Siscovick DS, Hoofnagle AN, Tracy R, Laughlin GA, Criqui MH, Budoff MJ, Li D, Ix JH. Bansal N, et al. J Clin Endocrinol Metab. 2013 Dec;98(12):4890-8. doi: 10.1210/jc.2013-2286. Epub 2013 Oct 3. J Clin Endocrinol Metab. 2013. PMID: 24092825 Free PMC article.

79

Controversies in osteoporosis management: antiresorptive therapy for preventing bone loss: when to use one or two antiresorptive agents?

Gallagher JC, Tella SH. Gallagher JC, et al. Clin Obstet Gynecol. 2013 Dec;56(4):749-56. doi: 10.1097/GRF.0b013e3182a982c2. Clin Obstet Gynecol. 2013. PMID: 24036481 Free PMC article. Review.

80

ACOG releases practice bulletin on osteoporosis.

Hauk L; American College of Obstetricians and Gynecologists. Hauk L, et al. Am Fam Physician. 2013 Aug 15;88(4):269-75. Am Fam Physician. 2013. PMID: 23944732 Free article. No abstract available.

81

New developments in the treatment of osteoporosis.

Eriksen EF, Halse J, Moen MH. Eriksen EF, et al. Acta Obstet Gynecol Scand. 2013 Jun;92(6):620-36. doi: 10.1111/j.1600-0412.2012.01473.x. Acta Obstet Gynecol Scand. 2013. PMID: 22646526 Free article. Review.

82

Analysis of the influence of hormone replacement therapy on TNF-alpha serum levels in menopausal women.

Rahnama M, Jamrogiewicz I, Jamrogiewicz R. Rahnama M, et al. Postepy Hig Med Dosw (Online). 2012 Dec 20;66:1006-11. doi: 10.5604/17322693.1024788. Postepy Hig Med Dosw (Online). 2012. PMID: 23687220 Free article.

83

Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution.

Fichna M, Zurawek M, Fichna P, Gryczynska M, Nowak J, Ruchala M. Fichna M, et al. J Physiol Pharmacol. 2012 Dec;63(6):677-82. J Physiol Pharmacol. 2012. PMID: 23388484 Free article.

84

Effects of a low-dose oral estrogen only treatment on bone mineral density and quantitative ultrasonometry in postmenopausal women.

Ziller M, Herwig J, Ziller V, Kauka A, Kostev K, Hadji P. Ziller M, et al. Gynecol Endocrinol. 2012 Dec;28(12):1002-5. doi: 10.3109/09513590.2012.705369. Epub 2012 Jul 26. Gynecol Endocrinol. 2012. PMID: 22835159 Free article.

85

[What patients need to know about the risk of bone fracture and its prevention].

Trémollières F. Trémollières F. J Gynecol Obstet Biol Reprod (Paris). 2012 Nov;41(7 Suppl):F20-7. doi: 10.1016/j.jgyn.2012.09.004. Epub 2012 Oct 2. J Gynecol Obstet Biol Reprod (Paris). 2012. PMID: 23040264 Free article. Review. French.

86

Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling.

Baliram R, Sun L, Cao J, Li J, Latif R, Huber AK, Yuen T, Blair HC, Zaidi M, Davies TF. Baliram R, et al. J Clin Invest. 2012 Oct;122(10):3737-41. doi: 10.1172/JCI63948. Epub 2012 Sep 17. J Clin Invest. 2012. PMID: 22996689 Free PMC article.

87

BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations.

Finch A, Evans G, Narod SA. Finch A, et al. Womens Health (Lond). 2012 Sep;8(5):543-55. doi: 10.2217/whe.12.41. Womens Health (Lond). 2012. PMID: 22934728 Free article.

88

Male osteoporosis.

Drake MT, Khosla S. Drake MT, et al. Endocrinol Metab Clin North Am. 2012 Sep;41(3):629-41. doi: 10.1016/j.ecl.2012.05.001. Epub 2012 Jun 17. Endocrinol Metab Clin North Am. 2012. PMID: 22877433 Free PMC article. Review.

89

[Biochemical bone markers and biological effects of osteoporosis therapy].

Kovacev-Zavisić B, Novaković-Paro J, Curić N, Icin T, Todorović-Djilas L, Kovacev N. Kovacev-Zavisić B, et al. Vojnosanit Pregl. 2012 May;69(5):432-6. doi: 10.2298/vsp1205432k. Vojnosanit Pregl. 2012. PMID: 22764547 Free article. Review. Serbian. No abstract available.

90

The 2012 hormone therapy position statement of: The North American Menopause Society.

North American Menopause Society. North American Menopause Society. Menopause. 2012 Mar;19(3):257-71. doi: 10.1097/gme.0b013e31824b970a. Menopause. 2012. PMID: 22367731 Free PMC article.

91

Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.

Bundred NJ, Kenemans P, Yip CH, Beckmann MW, Foidart JM, Sismondi P, Schoultz Bv, Vassilopoulou-Sellin R, Galta RE, Lieshout EV, Mol-Arts M, Planellas J, Kubista E. Bundred NJ, et al. Breast Cancer Res. 2012 Jan 17;14(1):R13. doi: 10.1186/bcr3097. Breast Cancer Res. 2012. PMID: 22251615 Free PMC article. Clinical Trial.

92

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey.

Meadows ES, Mitchell BD, Bolge SC, Johnston JA, Col NF. Meadows ES, et al. BMC Womens Health. 2012 Jan 6;12:1. doi: 10.1186/1472-6874-12-1. BMC Womens Health. 2012. PMID: 22225919 Free PMC article.

93

Primary prevention of cardiovascular disease with HRT.

Maclaran K, Stevenson JC. Maclaran K, et al. Womens Health (Lond). 2012 Jan;8(1):63-74. doi: 10.2217/whe.11.87. Womens Health (Lond). 2012. PMID: 22171776 Free article. Review.

94

Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients.

Kodama M, Komura H, Kodama T, Nishio Y, Kimura T. Kodama M, et al. Endocr J. 2012;59(2):153-9. doi: 10.1507/endocrj.ej11-0267. Epub 2011 Dec 3. Endocr J. 2012. PMID: 22139404 Free article.

95

Coping with time scales in disease systems analysis: application to bone remodeling.

Schmidt S, Post TM, Peletier LA, Boroujerdi MA, Danhof M. Schmidt S, et al. J Pharmacokinet Pharmacodyn. 2011 Dec;38(6):873-900. doi: 10.1007/s10928-011-9224-2. Epub 2011 Oct 26. J Pharmacokinet Pharmacodyn. 2011. PMID: 22028207 Free PMC article.

96

Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization.

Karim R, Dell RM, Greene DF, Mack WJ, Gallagher JC, Hodis HN. Karim R, et al. Menopause. 2011 Nov;18(11):1172-7. doi: 10.1097/gme.0b013e31821b01c7. Menopause. 2011. PMID: 21775911 Free PMC article.

97

Soy milk and dairy consumption is independently associated with ultrasound attenuation of the heel bone among postmenopausal women: the Adventist Health Study-2.

Matthews VL, Knutsen SF, Beeson WL, Fraser GE. Matthews VL, et al. Nutr Res. 2011 Oct;31(10):766-75. doi: 10.1016/j.nutres.2011.09.016. Nutr Res. 2011. PMID: 22074801 Free PMC article.

98

Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis.

Hansen KE, Wilson HA, Zapalowski C, Fink HA, Minisola S, Adler RA. Hansen KE, et al. J Bone Miner Res. 2011 Sep;26(9):1989-96. doi: 10.1002/jbmr.362. Epub 2011 Jun 30. J Bone Miner Res. 2011. PMID: 21721042 Free article. Review.

99

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).

Díez-Pérez A, Hooven FH, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Delmas P, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris ES, Watts NB, Nika G, Gehlbach SH. Díez-Pérez A, et al. Bone. 2011 Sep;49(3):493-8. doi: 10.1016/j.bone.2011.05.007. Epub 2011 May 14. Bone. 2011. PMID: 21605715 Free PMC article.

100

Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.

Hautmann AH, Elad S, Lawitschka A, Greinix H, Bertz H, Halter J, Faraci M, Hofbauer LC, Lee S, Wolff D, Holler E. Hautmann AH, et al. Transpl Int. 2011 Sep;24(9):867-79. doi: 10.1111/j.1432-2277.2011.01264.x. Epub 2011 May 9. Transpl Int. 2011. PMID: 21557780 Free article. Review.

101

The anti-osteoporotic effect of Eurycoma Longifolia in aged orchidectomised rat model.

Shuid AN, Abu Bakar MF, Abdul Shukor TA, Muhammad N, Mohamed N, Soelaiman IN. Shuid AN, et al. Aging Male. 2011 Sep;14(3):150-4. doi: 10.3109/13685538.2010.511327. Epub 2010 Sep 28. Aging Male. 2011. PMID: 20874437 Free article.

102

Do vaginal estrogens increase endometrial proliferation risk?

Andreini Poulsen S. Andreini Poulsen S. Am Fam Physician. 2011 Aug 15;84(4):354; author reply 354-5. Am Fam Physician. 2011. PMID: 21842780 Free article. No abstract available.

103

Higher bone mineral density is associated with a decreased risk of colorectal adenomas.

Nock NL, Patrick-Melin A, Cook M, Thompson C, Kirwan JP, Li L. Nock NL, et al. Int J Cancer. 2011 Aug 15;129(4):956-64. doi: 10.1002/ijc.25722. Epub 2010 Dec 8. Int J Cancer. 2011. PMID: 20949624 Free PMC article.

104

Individualizing hormone therapy to minimize risk: accurate assessment of risks and benefits.

Shoupe D. Shoupe D. Womens Health (Lond). 2011 Jul;7(4):475-85. doi: 10.2217/whe.11.42. Womens Health (Lond). 2011. PMID: 21790340 Free article. Review.

105

Too much of a good thing: female athlete triad.

Powell L. Powell L. Mo Med. 2011 May-Jun;108(3):176-8. Mo Med. 2011. PMID: 21736076 Free PMC article.

106

Severe osteoporosis with multiple vertebral fractures after gender reassignment therapy - is it male or female osteoporosis?

Fischer EM, Patsch J, Muschitz C, Becker S, Resch H. Fischer EM, et al. Gynecol Endocrinol. 2011 May;27(5):341-4. doi: 10.3109/09513590.2010.491926. Epub 2010 Jun 14. Gynecol Endocrinol. 2011. PMID: 20540674 Free article.

107

Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study.

Fraser LA, Ioannidis G, Adachi JD, Pickard L, Kaiser SM, Prior J, Brown JP, Hanley DA, Olszynski WP, Anastassiades T, Jamal S, Josse R, Goltzman D, Papaioannou A; CaMos Research Group. Fraser LA, et al. Osteoporos Int. 2011 Mar;22(3):789-96. doi: 10.1007/s00198-010-1359-2. Epub 2010 Aug 4. Osteoporos Int. 2011. PMID: 20683706 Free PMC article.

108

Hormonal therapy with estradiol and testosterone implants: bone protection?

Britto R, Araújo L, Barbosa I, Silva L, Rocha S, Valente AP. Britto R, et al. Gynecol Endocrinol. 2011 Feb;27(2):96-100. doi: 10.3109/09513590.2010.489131. Epub 2010 May 26. Gynecol Endocrinol. 2011. PMID: 20504104 Free article. Clinical Trial.

109

Premature ovarian failure.

Maclaran K, Panay N. Maclaran K, et al. J Fam Plann Reprod Health Care. 2011 Jan;37(1):35-42. doi: 10.1136/jfprhc.2010.0015. J Fam Plann Reprod Health Care. 2011. PMID: 21367702 Free article. Review.

110

The role of hormonal therapy in osteoporosis.

Horst-Sikorska W, Wawrzyniak A. Horst-Sikorska W, et al. Endokrynol Pol. 2011 Jan-Feb;62(1):61-4. Endokrynol Pol. 2011. PMID: 21365581 Free article. Review.

111

Women with primary ovarian insufficiency have lower bone mineral density.

Amarante F, Vilodre LC, Maturana MA, Spritzer PM. Amarante F, et al. Braz J Med Biol Res. 2011 Jan;44(1):78-83. doi: 10.1590/s0100-879x2010007500122. Epub 2010 Nov 12. Braz J Med Biol Res. 2011. PMID: 21085897 Free article.

112

Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.

Mäkinen JI, Huhtaniemi I. Mäkinen JI, et al. Gerontology. 2011;57(3):193-202. doi: 10.1159/000319635. Epub 2010 Aug 2. Gerontology. 2011. PMID: 20689266 Free article. Review.

113

Glucocorticoid-induced osteoporosis.

Thacker H. Thacker H. Cleve Clin J Med. 2010 Dec;77(12):843; author reply 843-4. Cleve Clin J Med. 2010. PMID: 21186693 Free article. No abstract available.

114

Counseling patients about hormone therapy and alternatives for menopausal symptoms.

Hill DA, Hill SR. Hill DA, et al. Am Fam Physician. 2010 Oct 1;82(7):801-7. Am Fam Physician. 2010. PMID: 20879703 Free article.

115

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.

Body JJ, Bergmann P, Boonen S, Boutsen Y, Devogelaer JP, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY. Body JJ, et al. Osteoporos Int. 2010 Oct;21(10):1657-80. doi: 10.1007/s00198-010-1223-4. Epub 2010 May 18. Osteoporos Int. 2010. PMID: 20480148 Free PMC article.

116

How to prevent glucocorticoid-induced osteoporosis.

Dore RK. Dore RK. Cleve Clin J Med. 2010 Aug;77(8):529-36. doi: 10.3949/ccjm.77a.10003. Cleve Clin J Med. 2010. PMID: 20682515 Free article. Review.

117

Updated clinical recommendations for the use of tibolone in Asian women.

Huang KE, Baber R; Asia Pacific Tibolone Consensus Group. Huang KE, et al. Climacteric. 2010 Aug;13(4):317-27. doi: 10.3109/13697131003681458. Climacteric. 2010. PMID: 20443720 Free PMC article. Review.

118

Influence of arthritis and non-arthritis related factors on areal bone mineral density (BMDa) in women with longstanding inflammatory polyarthritis: a primary care based inception cohort.

Pye SR, Marshall T, Gaffney K, Silman AJ, Symmons DP, O'Neill TW. Pye SR, et al. BMC Musculoskelet Disord. 2010 May 28;11:106. doi: 10.1186/1471-2474-11-106. BMC Musculoskelet Disord. 2010. PMID: 20509941 Free PMC article.

119

Long-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribing.

Lee E, Maneno MK, Wutoh AK, Zuckerman IH. Lee E, et al. J Womens Health (Larchmt). 2010 May;19(5):847-54. doi: 10.1089/jwh.2009.1441. J Womens Health (Larchmt). 2010. PMID: 20459329 Free PMC article.

120

Association with replication between estrogen-related receptor gamma (ESRRgamma) polymorphisms and bone phenotypes in women of European ancestry.

Elfassihi L, Giroux S, Bureau A, Laflamme N, Cole DE, Rousseau F. Elfassihi L, et al. J Bone Miner Res. 2010 Apr;25(4):901-11. doi: 10.1359/jbmr.091014. J Bone Miner Res. 2010. PMID: 19821770 Free article.

121

Baseline serum estradiol and fracture reduction during treatment with hormone therapy: the Women's Health Initiative randomized trial.

Cauley JA, LaCroix AZ, Robbins JA, Larson J, Wallace R, Wactawski-Wende J, Chen Z, Bauer DC, Cummings SR, Jackson R. Cauley JA, et al. Osteoporos Int. 2010 Jan;21(1):167-77. doi: 10.1007/s00198-009-0953-7. Epub 2009 May 13. Osteoporos Int. 2010. PMID: 19436934 Free PMC article. Clinical Trial.

122

Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?

Alexandersen P, Karsdal MA, Christiansen C. Alexandersen P, et al. Womens Health (Lond). 2009 Nov;5(6):637-47. doi: 10.2217/whe.09.52. Womens Health (Lond). 2009. PMID: 19863467 Free article.

123

Is HRT still indicated for the primary prevention of osteoporosis?

Birkhäuser MH. Birkhäuser MH. Gynecol Endocrinol. 2009 Oct;25(10):629-33. doi: 10.1080/09513590903056746. Gynecol Endocrinol. 2009. PMID: 19626509 Free article. No abstract available.

124

Beneficial aspect of oral estriol as hormone replacement therapy: consideration on bone and lipid metabolism.

Kika G, Izumi S, Mori A, Murano T, Suzuki T, Cai LY, Nakamura E, Goya K, Maeda H, Uchida N, Shida M. Kika G, et al. Tokai J Exp Clin Med. 2009 Sep 20;34(3):92-8. Tokai J Exp Clin Med. 2009. PMID: 21319007 Free article. Clinical Trial.

125

Comment on Kanis et al.: "European guidance for the diagnosis and management of osteoporosis in postmenopausal women".

Clausen JO. Clausen JO. Osteoporos Int. 2009 Sep;20(9):1631. doi: 10.1007/s00198-008-0812-y. Epub 2008 Dec 16. Osteoporos Int. 2009. PMID: 19085029 Free PMC article. No abstract available.

126

Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats.

Stuermer EK, Sehmisch S, Tezval M, Tezval H, Rack T, Boekhoff J, Wuttke W, Herrmann TR, Seidlova-Wuttke D, Stuermer KM. Stuermer EK, et al. World J Urol. 2009 Aug;27(4):547-55. doi: 10.1007/s00345-009-0373-5. Epub 2009 Feb 17. World J Urol. 2009. PMID: 19221760 Free PMC article.

127

Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial.

McTiernan A, Wactawski-Wende J, Wu L, Rodabough RJ, Watts NB, Tylavsky F, Freeman R, Hendrix S, Jackson R; Women's Health Initiative Investigators. McTiernan A, et al. Am J Clin Nutr. 2009 Jun;89(6):1864-76. doi: 10.3945/ajcn.2008.26956. Epub 2009 Apr 29. Am J Clin Nutr. 2009. PMID: 19403636 Free PMC article. Clinical Trial.

128

The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes.

Brodowska A, Starczewski A, Brodowski J, Szydłowska I, Nawrocka-Rutkowska J. Brodowska A, et al. Gynecol Endocrinol. 2009 May;25(5):315-23. doi: 10.1080/09513590802630138. Gynecol Endocrinol. 2009. PMID: 19903038 Free article.

129

Nightshift work and fracture risk: the Nurses' Health Study.

Feskanich D, Hankinson SE, Schernhammer ES. Feskanich D, et al. Osteoporos Int. 2009 Apr;20(4):537-42. doi: 10.1007/s00198-008-0729-5. Epub 2008 Sep 3. Osteoporos Int. 2009. PMID: 18766292 Free PMC article.

130

Clinical practice. Primary ovarian insufficiency.

Nelson LM. Nelson LM. N Engl J Med. 2009 Feb 5;360(6):606-14. doi: 10.1056/NEJMcp0808697. N Engl J Med. 2009. PMID: 19196677 Free PMC article. Review.

131

Diagnosis and treatment of osteoporosis.

Sweet MG, Sweet JM, Jeremiah MP, Galazka SS. Sweet MG, et al. Am Fam Physician. 2009 Feb 1;79(3):193-200. Am Fam Physician. 2009. PMID: 19202966 Free article. Review.

132

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.

Kenemans P, Bundred NJ, Foidart JM, Kubista E, von Schoultz B, Sismondi P, Vassilopoulou-Sellin R, Yip CH, Egberts J, Mol-Arts M, Mulder R, van Os S, Beckmann MW; LIBERATE Study Group. Kenemans P, et al. Lancet Oncol. 2009 Feb;10(2):135-46. doi: 10.1016/S1470-2045(08)70341-3. Epub 2009 Jan 23. Lancet Oncol. 2009. PMID: 19167925 Free article. Clinical Trial.

133

Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study.

Caire-Juvera G, Ritenbaugh C, Wactawski-Wende J, Snetselaar LG, Chen Z. Caire-Juvera G, et al. Am J Clin Nutr. 2009 Jan;89(1):323-30. doi: 10.3945/ajcn.2008.26451. Epub 2008 Dec 3. Am J Clin Nutr. 2009. PMID: 19056568 Free PMC article.

134

Advances in hormone replacement therapy: making the menopause manageable.

Palacios S. Palacios S. BMC Womens Health. 2008 Nov 27;8:22. doi: 10.1186/1472-6874-8-22. BMC Womens Health. 2008. PMID: 19038018 Free PMC article. Review.

135

Tibolone in older postmenopausal women.

Chlebowski RT, Prentice R. Chlebowski RT, et al. N Engl J Med. 2008 Nov 13;359(20):2172-3; author reply 2173. doi: 10.1056/NEJMc081934. N Engl J Med. 2008. PMID: 19005202 Free article. No abstract available.

136

Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates.

Al-Azzawi F. Al-Azzawi F. Gynecol Endocrinol. 2008 Nov;24(11):601-9. doi: 10.1080/09513590802296245. Gynecol Endocrinol. 2008. PMID: 19031214 Free article. No abstract available.

137

Estrogen and progestogen therapy in postmenopausal women.

Practice Committee of American Society for Reproductive Medicine. Practice Committee of American Society for Reproductive Medicine. Fertil Steril. 2008 Nov;90(5 Suppl):S88-102. doi: 10.1016/j.fertnstert.2008.08.091. Fertil Steril. 2008. PMID: 19007655 Free article. Review.

138

Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women.

Syed FA, Oursler MJ, Hefferanm TE, Peterson JM, Riggs BL, Khosla S. Syed FA, et al. Osteoporos Int. 2008 Sep;19(9):1323-30. doi: 10.1007/s00198-008-0574-6. Epub 2008 Feb 15. Osteoporos Int. 2008. PMID: 18274695 Free PMC article. Clinical Trial.

139

The effects of tibolone in older postmenopausal women.

Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, Mol-Arts M, Kloosterboer L, Mosca L, Christiansen C, Bilezikian J, Kerzberg EM, Johnson S, Zanchetta J, Grobbee DE, Seifert W, Eastell R; LIFT Trial Investigators. Cummings SR, et al. N Engl J Med. 2008 Aug 14;359(7):697-708. doi: 10.1056/NEJMoa0800743. N Engl J Med. 2008. PMID: 18703472 Free PMC article. Clinical Trial.

140

Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older.

Gourlay ML, Powers JM, Lui LY, Ensrud KE; Study of Osteoporotic Fractures Research Group. Gourlay ML, et al. Osteoporos Int. 2008 Aug;19(8):1175-83. doi: 10.1007/s00198-007-0555-1. Epub 2008 Jan 25. Osteoporos Int. 2008. PMID: 18219434 Free PMC article.

141

Hormone-dependent aging problems in women.

Jung BH, Jeon MJ, Bai SW. Jung BH, et al. Yonsei Med J. 2008 Jun 30;49(3):345-51. doi: 10.3349/ymj.2008.49.3.345. Yonsei Med J. 2008. PMID: 18581581 Free PMC article. Review.

142

A more active role for gynecologists in the prevention of postmenopausal osteoporosis.

Ylikorkala O. Ylikorkala O. Gynecol Endocrinol. 2008 Jun;24(6):293-4. doi: 10.1080/09513590802243403. Gynecol Endocrinol. 2008. PMID: 18584406 Free article. No abstract available.

143

Putting the latest data into practice: case studies and clinical considerations in menopausal management.

McKenzie M, Sikon AL, Thacker HL, Gass M, Hodis HN, Jenkins MR. McKenzie M, et al. Cleve Clin J Med. 2008 May;75 Suppl 4:S25-33. doi: 10.3949/ccjm.75.suppl_4.s25. Cleve Clin J Med. 2008. PMID: 18693639 Free article. No abstract available.

144

Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.

Lukes A. Lukes A. J Manag Care Pharm. 2008 Apr;14(3 Suppl):7-13. doi: 10.18553/jmcp.2008.14.S3-A.7. J Manag Care Pharm. 2008. PMID: 18439061 Free PMC article. Review.

145

Gender differences in health care expenditures, resource utilization, and quality of care.

Owens GM. Owens GM. J Manag Care Pharm. 2008 Apr;14(3 Suppl):2-6. doi: 10.18553/jmcp.2008.14.S6-A.2. J Manag Care Pharm. 2008. PMID: 18439060 Free PMC article. Review.

146

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, Rizzoli R; European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Kanis JA, et al. Osteoporos Int. 2008 Apr;19(4):399-428. doi: 10.1007/s00198-008-0560-z. Epub 2008 Feb 12. Osteoporos Int. 2008. PMID: 18266020 Free PMC article. Review.

147

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis.

MacLean C, Newberry S, Maglione M, McMahon M, Ranganath V, Suttorp M, Mojica W, Timmer M, Alexander A, McNamara M, Desai SB, Zhou A, Chen S, Carter J, Tringale C, Valentine D, Johnsen B, Grossman J. MacLean C, et al. Ann Intern Med. 2008 Feb 5;148(3):197-213. doi: 10.7326/0003-4819-148-3-200802050-00198. Epub 2007 Dec 17. Ann Intern Med. 2008. PMID: 18087050 Free article.

148

Treatment of postmenopausal osteoporosis in women: a systematic review.

Brandão CM, Lima MG, Silva AL, Silva GD, Guerra AA Jr, Acúrcio Fde A. Brandão CM, et al. Cad Saude Publica. 2008;24 Suppl 4:s592-606. doi: 10.1590/s0102-311x2008001600011. Cad Saude Publica. 2008. PMID: 18797733 Free article. Review.

149

Transdermal hormone therapy and bone health.

Shulman LP. Shulman LP. Clin Interv Aging. 2008;3(1):51-4. doi: 10.2147/cia.s937. Clin Interv Aging. 2008. PMID: 18488878 Free PMC article. Review.

150

Risk factors for osteoporosis and bone status in postmenopausal women with psoriasis treated with UVB therapy.

Osmancevic A, Landin-Wilhelmsen K, Larkö O, Mellström D, Wennberg AM, Hulthén L, Krogstad AL. Osmancevic A, et al. Acta Derm Venereol. 2008;88(3):240-6. doi: 10.2340/00015555-0403. Acta Derm Venereol. 2008. PMID: 18480922 Free article.

151

Transdermal natural progesterone cream for postmenopausal women: inconsistent data and complex pharmacokinetics.

Elshafie MA, Ewies AA. Elshafie MA, et al. J Obstet Gynaecol. 2007 Oct;27(7):655-9. doi: 10.1080/01443610701582727. J Obstet Gynaecol. 2007. PMID: 17999287 Free article. Review.

152

Long-term effects of progestins on bone quality and fractures.

Thijssen JH. Thijssen JH. Gynecol Endocrinol. 2007 Oct;23 Suppl 1:45-52. doi: 10.1080/09513590701584931. Gynecol Endocrinol. 2007. PMID: 17943539 Free article. Review.

153

The Women's Health Initiative and hormone therapy, 5 years later.

Johnson SR. Johnson SR. Cleve Clin J Med. 2007 Oct;74(10):755-6. doi: 10.3949/ccjm.74.10.755. Cleve Clin J Med. 2007. PMID: 17941297 Free article. No abstract available.

154

Estrogen therapy and coronary-artery calcification.

Hofbauer LC, Khosla S, Schoppet M. Hofbauer LC, et al. N Engl J Med. 2007 Sep 20;357(12):1253-4; author reply 1254. N Engl J Med. 2007. PMID: 17891834 Free article. No abstract available.

155

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.

Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, DeStavola BL, Rose S, Dowell A, Wilkes HC, Darbyshire JH, Meade TW; WISDOM group. Vickers MR, et al. BMJ. 2007 Aug 4;335(7613):239. doi: 10.1136/bmj.39266.425069.AD. Epub 2007 Jul 11. BMJ. 2007. PMID: 17626056 Free PMC article. Clinical Trial.

156

Turner syndrome: diagnosis and management.

Morgan T. Morgan T. Am Fam Physician. 2007 Aug 1;76(3):405-10. Am Fam Physician. 2007. PMID: 17708142 Free article. Review.

157

Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol.

Su JL, Yang CY, Zhao M, Kuo ML, Yen ML. Su JL, et al. J Biol Chem. 2007 Jul 6;282(27):19385-98. doi: 10.1074/jbc.M702452200. Epub 2007 May 18. J Biol Chem. 2007. PMID: 17513867 Free article.

158

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.

Dane C, Dane B, Cetin A, Erginbas M. Dane C, et al. Gynecol Endocrinol. 2007 Jul;23(7):398-403. doi: 10.1080/09513590701414907. Gynecol Endocrinol. 2007. PMID: 17701771 Free article. Clinical Trial.

159

The expression of estrogen receptors and the effects of estrogen on human periodontal ligament cells.

Cao M, Shu L, Li J, Su J, Zhang W, Wang Q, Guo T, Ding Y. Cao M, et al. Methods Find Exp Clin Pharmacol. 2007 Jun;29(5):329-35. doi: 10.1358/mf.2007.29.5.1117560. Methods Find Exp Clin Pharmacol. 2007. PMID: 17805434 Free article.

160

Effects of tibolone on the breast of postmenopausal women.

Wang PH, Cheng MH, Chao HT, Chao KC. Wang PH, et al. Taiwan J Obstet Gynecol. 2007 Jun;46(2):121-6. doi: 10.1016/S1028-4559(07)60005-9. Taiwan J Obstet Gynecol. 2007. PMID: 17638619 Free article. Review.

161

A clinical trial of 3 doses of transdermal 17beta-estradiol for preventing postmenopausal bone loss: a preliminary study.

Yang TS, Chen YJ, Liang WH, Chang CY, Tai LC, Chang SP, Ng HT. Yang TS, et al. J Chin Med Assoc. 2007 May;70(5):200-6. doi: 10.1016/S1726-4901(09)70358-2. J Chin Med Assoc. 2007. PMID: 17524997 Free article. Clinical Trial.

162

Newer hormonal therapies: lower doses; oral, transdermal, and vaginal formulations.

Sivanandy MS, Masimasi N, Thacker HL. Sivanandy MS, et al. Cleve Clin J Med. 2007 May;74(5):369-75. doi: 10.3949/ccjm.74.5.369. Cleve Clin J Med. 2007. PMID: 17506242 Free article. Review.

163

Bone mineral density and age-related maculopathy in older women.

Seitzman RL, Mangione CM, Cauley JA, Ensrud KE, Stone KL, Cummings SR, Hochberg MC, Hillier TA, Yu F, Coleman AL; Study of Osteoporotic Fractures Research Group. Seitzman RL, et al. J Am Geriatr Soc. 2007 May;55(5):740-6. doi: 10.1111/j.1532-5415.2007.01138.x. J Am Geriatr Soc. 2007. PMID: 17493194 Free article.

164

The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappaB legend with bone mineral density in older adults: the Rancho Bernardo study.

Stern A, Laughlin GA, Bergstrom J, Barrett-Connor E. Stern A, et al. Eur J Endocrinol. 2007 May;156(5):555-62. doi: 10.1530/EJE-06-0753. Eur J Endocrinol. 2007. PMID: 17468191 Free PMC article.

165

Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.

Huang WF, Tsai YW, Hsiao FY, Liu WC. Huang WF, et al. BMC Public Health. 2007 Apr 17;7:56. doi: 10.1186/1471-2458-7-56. BMC Public Health. 2007. PMID: 17439639 Free PMC article.

166

[Prevention of osteoporosis].

Vujasinović-Stupar N, Radojcić L, Nenadić D. Vujasinović-Stupar N, et al. Vojnosanit Pregl. 2007 Mar;64(3):205-10. doi: 10.2298/vsp0703205v. Vojnosanit Pregl. 2007. PMID: 17438967 Free article. Review. Serbian. No abstract available.

167

Osteoporosis screening and risk management.

Wilkins CH. Wilkins CH. Clin Interv Aging. 2007;2(3):389-94. Clin Interv Aging. 2007. PMID: 18044189 Free PMC article.

168

The osteoporotic male: overlooked and undermanaged?

Madeo B, Zirilli L, Caffagni G, Diazzi C, Sanguanini A, Pignatti E, Carani C, Rochira V. Madeo B, et al. Clin Interv Aging. 2007;2(3):305-12. Clin Interv Aging. 2007. PMID: 18044181 Free PMC article. Review.

169

Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists.

Pedersen AT, Iversen OE, Løkkegaard E, Mattsson LA, Milsom I, Nilsen ST, Ottesen B, Moen MH. Pedersen AT, et al. Acta Obstet Gynecol Scand. 2007;86(12):1490-5. doi: 10.1080/00016340701745418. Acta Obstet Gynecol Scand. 2007. PMID: 18027116 Free article.

170

Assessing the content and quality of information on the treatment of postmenopausal osteoporosis on the World Wide Web.

Pérez-López FR, Pérez Roncero GR. Pérez-López FR, et al. Gynecol Endocrinol. 2006 Dec;22(12):669-75. doi: 10.1080/09513590601012603. Gynecol Endocrinol. 2006. PMID: 17162708 Free article.

171

Estrogen and progestogen therapy in postmenopausal women.

Practice Committee of the American Society for Reproductive Medicine. Practice Committee of the American Society for Reproductive Medicine. Fertil Steril. 2006 Nov;86(5 Suppl 1):S75-88. doi: 10.1016/j.fertnstert.2006.07.1476. Fertil Steril. 2006. PMID: 17055850 Free article. No abstract available.

172

[Osteoporosis treatment in Portugal: trends and geographical variation].

Rocha O, Lunet N, Costa L, Barros H. Rocha O, et al. Acta Med Port. 2006 Sep-Oct;19(5):373-80. Epub 2007 Mar 8. Acta Med Port. 2006. PMID: 17376323 Free article. Portuguese.

173

Prescription drug therapies for prevention and treatment of postmenopausal osteoporosis.

O'Connell MB. O'Connell MB. J Manag Care Pharm. 2006 Jul;12(6 Suppl A):S10-9; quiz S26-8. doi: 10.18553/jmcp.2006.12.S6-A.S10. J Manag Care Pharm. 2006. PMID: 17269853 Free PMC article.

174

Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.

Yüksel H, Odabaşi AR, Demircan S, Karul A, Kozaci LD, Köseoğlu K, Kizilkaya K, Başak O. Yüksel H, et al. Gynecol Endocrinol. 2006 Jul;22(7):381-7. doi: 10.1080/09513590600842281. Gynecol Endocrinol. 2006. PMID: 16864148 Free article. Clinical Trial.

175

The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.

Genazzani AR, Schneider HP, Panay N, Nijland EA. Genazzani AR, et al. Gynecol Endocrinol. 2006 Jul;22(7):369-75. doi: 10.1080/09513590600842463. Gynecol Endocrinol. 2006. PMID: 16864146 Free article.

176

Premenopausal women and low bone density.

Khan A. Khan A. Can Fam Physician. 2006 Jun;52(6):743-7. Can Fam Physician. 2006. PMID: 16812966 Free PMC article. Review.

177

Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?

Petrella RJ, Jones TJ. Petrella RJ, et al. BMC Fam Pract. 2006 May 9;7:31. doi: 10.1186/1471-2296-7-31. BMC Fam Pract. 2006. PMID: 16684358 Free PMC article.

178

Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.

Udell JA, Fischer MA, Brookhart MA, Solomon DH, Choudhry NK. Udell JA, et al. J Bone Miner Res. 2006 May;21(5):765-71. doi: 10.1359/jbmr.060119. J Bone Miner Res. 2006. PMID: 16734392 Free article.

179

García-Pérez MA, Moreno-Mercer J, Tarín JJ, Cano A. García-Pérez MA, et al. Gynecol Endocrinol. 2006 Apr;22(4):179-84. doi: 10.1080/09513590600624291. Gynecol Endocrinol. 2006. PMID: 16723303 Free article. Clinical Trial.

180

Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy.

Notelovitz M. Notelovitz M. MedGenMed. 2006 Mar 28;8(1):84. MedGenMed. 2006. PMID: 16915214 Free PMC article. Review.

181

Pharmaceutical prospects of phytoestrogens.

Usui T. Usui T. Endocr J. 2006 Feb;53(1):7-20. doi: 10.1507/endocrj.53.7. Endocr J. 2006. PMID: 16543667 Free article. Review.

182

Osteoporosis: current trends in diagnosis and management.

Kulenović I, Rasić S, Kulenović E. Kulenović I, et al. Bosn J Basic Med Sci. 2006 Feb;6(1):24-8. doi: 10.17305/bjbms.2006.3205. Bosn J Basic Med Sci. 2006. PMID: 16533175 Free PMC article. Review.

183

Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.

Ste-Marie LG, Schwartz SL, Hossain A, Desaiah D, Gaich GA. Ste-Marie LG, et al. J Bone Miner Res. 2006 Feb;21(2):283-91. doi: 10.1359/JBMR.051020. Epub 2005 Oct 31. J Bone Miner Res. 2006. PMID: 16418784 Free article. Clinical Trial.

184

Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women.

Jordan N, Barry M, Murphy E. Jordan N, et al. Clin Interv Aging. 2006;1(4):377-87. doi: 10.2147/ciia.2006.1.4.377. Clin Interv Aging. 2006. PMID: 18046915 Free PMC article. Review.

185

[Hormone replacement therapy: curse or blessing?].

Schmidt M, Fink D, Lang U, Kimmig R. Schmidt M, et al. Gynakol Geburtshilfliche Rundsch. 2006;46(4):165. doi: 10.1159/000095724. Gynakol Geburtshilfliche Rundsch. 2006. PMID: 17068400 Free article. German.

186

The heart of drug discovery and development: rational target selection.

Spector R, Vesell ES. Spector R, et al. Pharmacology. 2006;77(2):85-92. doi: 10.1159/000093166. Epub 2006 May 5. Pharmacology. 2006. PMID: 16679815 Free article.

187

Hormone therapy for the prevention of chronic conditions in postmenopausal women.

Guirguis-Blake J. Guirguis-Blake J. Am Fam Physician. 2005 Dec 15;72(12):2520-2. Am Fam Physician. 2005. PMID: 16370410 Free article. No abstract available.

188

Efficacy and safety of 17alpha-hydroxyprogesterone caproate in hormone replacement therapy.

Agostini R, Casini ML, Costabile L, Paragona M, Marzano F, Unfer V. Agostini R, et al. Gynecol Endocrinol. 2005 Nov;21(5):265-7. doi: 10.1080/09513590500368650. Gynecol Endocrinol. 2005. PMID: 16373245 Free article.

189

Estimated numbers of postmenopausal women treated by hormone therapy in France.

Gayet-Ageron A, Amamra N, Ringa V, Tainturier V, Berr C, Clavel-Chapelon F, Delcourt C, Delmas PD, Ducimetière P, Schott AM. Gayet-Ageron A, et al. Maturitas. 2005 Nov-Dec;52(3-4):296-305. doi: 10.1016/j.maturitas.2005.05.002. Epub 2005 Jun 13. Maturitas. 2005. PMID: 15955641 Free PMC article.

190

Female athlete triad. Each of the following statements about treatment for menstrual disturbances and decreased bone mineral density in female athletes is true except.

[No authors listed] [No authors listed] Can Fam Physician. 2005 Oct;51(10):1338, 1344-5. Can Fam Physician. 2005. PMID: 16250419 Free PMC article. No abstract available.

191

Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial.

Greenspan SL, Beck TJ, Resnick NM, Bhattacharya R, Parker RA. Greenspan SL, et al. J Bone Miner Res. 2005 Sep;20(9):1525-32. doi: 10.1359/JBMR.050508. Epub 2005 May 9. J Bone Miner Res. 2005. PMID: 16059624 Free article. Clinical Trial.

192

Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study.

Ruetsche AG, Kneubuehl R, Birkhaeuser MH, Lippuner K. Ruetsche AG, et al. Osteoporos Int. 2005 Jul;16(7):791-8. doi: 10.1007/s00198-004-1754-7. Epub 2004 Oct 16. Osteoporos Int. 2005. PMID: 15502960 Free article.

193

Fracture prevention in postmenopausal women.

Bruyere O, Edwards J, Reginster JY. Bruyere O, et al. Clin Evid. 2005 Jun;(13):1419-34. Clin Evid. 2005. Update in: Clin Evid. 2006 Jun;(15):1543-60. PMID: 16135297 Free article. Updated. Review. No abstract available.

194

Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.

Licznerska BE, Baer-Dubowska W. Licznerska BE, et al. Acta Pol Pharm. 2005 May-Jun;62(3):241-7. Acta Pol Pharm. 2005. PMID: 16193819 Free article.

195

Treatment of postmenopausal osteoporosis.

Reginster JY. Reginster JY. BMJ. 2005 Apr 16;330(7496):859-60. doi: 10.1136/bmj.330.7496.859. BMJ. 2005. PMID: 15831851 Free PMC article. No abstract available.

196

Treatment of postmenopausal osteoporosis.

Greenblatt D. Greenblatt D. Pharmacotherapy. 2005 Apr;25(4):574-84. doi: 10.1592/phco.25.4.574.61031. Pharmacotherapy. 2005. PMID: 15977918 Free article. Review.

197

Hormone replacement therapy in postmenopausal women.

Prelevic GM, Kocjan T, Markou A. Prelevic GM, et al. Minerva Endocrinol. 2005 Mar;30(1):27-36. Minerva Endocrinol. 2005. PMID: 15877011 Free article. Review.

198

Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone.

Albagha OM, Pettersson U, Stewart A, McGuigan FE, MacDonald HM, Reid DM, Ralston SH. Albagha OM, et al. J Med Genet. 2005 Mar;42(3):240-6. doi: 10.1136/jmg.2004.023895. J Med Genet. 2005. PMID: 15744038 Free PMC article.

199

Effects of endogenous estrogen on renal calcium and phosphate handling in elderly women.

Dick IM, Devine A, Beilby J, Prince RL. Dick IM, et al. Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E430-5. doi: 10.1152/ajpendo.00140.2004. Epub 2004 Oct 5. Am J Physiol Endocrinol Metab. 2005. PMID: 15466921 Free article. Clinical Trial.

200

Potential impact of subject-based risk factor control on periodontitis.

Ramseier CA. Ramseier CA. J Clin Periodontol. 2005;32 Suppl 6:283-90. doi: 10.1111/j.1600-051X.2005.00798.x. J Clin Periodontol. 2005. PMID: 16128842 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

457 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Results by year